Last Updated: May 24, 2026

Suppliers and packagers for wera


✉ Email this page to a colleague

« Back to Dashboard


wera

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Novast Labs Ltd WERA ethinyl estradiol; norethindrone TABLET;ORAL-28 091204 ANDA Northstar Rx LLC 16714-370-01 1 BLISTER PACK in 1 PACKET (16714-370-01) / 1 KIT in 1 BLISTER PACK 2012-03-27
Novast Labs Ltd WERA ethinyl estradiol; norethindrone TABLET;ORAL-28 091204 ANDA Northstar Rx LLC 16714-370-02 1 BLISTER PACK in 1 CARTON (16714-370-02) / 1 KIT in 1 BLISTER PACK 2012-03-27
Novast Labs Ltd WERA ethinyl estradiol; norethindrone TABLET;ORAL-28 091204 ANDA Northstar Rx LLC 16714-370-03 3 BLISTER PACK in 1 CARTON (16714-370-03) / 1 KIT in 1 BLISTER PACK 2012-03-27
Novast Labs Ltd WERA ethinyl estradiol; norethindrone TABLET;ORAL-28 091204 ANDA Northstar Rx LLC 16714-370-04 6 BLISTER PACK in 1 CARTON (16714-370-04) / 1 KIT in 1 BLISTER PACK 2012-03-27
Novast Labs Ltd WERA ethinyl estradiol; norethindrone TABLET;ORAL-28 091204 ANDA Mayne Pharma Inc. 51862-892-01 1 BLISTER PACK in 1 PACKET (51862-892-01) / 1 KIT in 1 BLISTER PACK 2020-10-12
Novast Labs Ltd WERA ethinyl estradiol; norethindrone TABLET;ORAL-28 091204 ANDA Mayne Pharma Inc. 51862-892-02 1 BLISTER PACK in 1 CARTON (51862-892-02) / 1 KIT in 1 BLISTER PACK 2020-10-12
Novast Labs Ltd WERA ethinyl estradiol; norethindrone TABLET;ORAL-28 091204 ANDA Mayne Pharma Inc. 51862-892-06 6 BLISTER PACK in 1 CARTON (51862-892-06) / 1 KIT in 1 BLISTER PACK 2020-10-12
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for wera

Last updated: May 5, 2026

Who Supplies the Pharmaceutical Drug “WERA”?

No complete and accurate supplier identification is possible from the information provided.

Is “WERA” a Drug Substance, Brand, or Product Code?

“WERA” is not uniquely identifiable as a pharmaceutical drug name, active pharmaceutical ingredient (API), finished dosage form, or regulated product code from the supplied text alone. Without a definitive mapping to a specific marketed product (country, legal name, INN/USAN, dosage form, strength, MAH, and regulatory dossier identifiers), supplier lists would risk mixing unrelated products and counterfeit or parallel listings.

Can Suppliers Be Determined Without Product-Identity Anchors?

Supplier identification in pharmaceutical supply chains depends on product identity anchors such as:

  • Marketing authorization holder (MAH) and manufacturer of record (finished dosage)
  • API manufacturer(s) and intermediate supplier(s)
  • Labeling details (active ingredient name, strength, dosage form)
  • Regulatory listing (EMA, FDA, national registries), plus product lifecycle events

Those anchors are not present in the prompt.


Key Takeaways

  • “WERA” cannot be mapped to a single pharmaceutical drug with the required certainty to produce a supplier list.
  • Supplier identification requires regulatory-grade product identity fields (INN/USAN/brand mapping, dosage form, strength, and jurisdiction).

FAQs

  1. What counts as a “supplier” for a pharmaceutical drug?
    API manufacturer(s), finished dosage manufacturer(s) (contract manufacturing and labeling), and MAH are the core supplier categories.

  2. Why can’t brand names always be converted to suppliers?
    Brand strings can map to multiple products across jurisdictions and dose formats, and the same string can be used as a code name, distributor label, or counterfeit branding.

  3. Which sources usually provide supplier-grade information?
    Regulatory product databases, MAH/labeling sections, EMA/FDA product listings, and dossier disclosures via public regulatory documents.

  4. Does “WERA” likely refer to a specific INN?
    The provided text does not establish whether “WERA” is an INN, brand, combination, or internal code.

  5. Can a supplier list be generated without knowing dosage form and strength?
    For accurate supplier mapping, those attributes typically must be specified because manufacturing and packaging can vary by strength and presentation.


References

[1] No sources were provided or retrievable from the prompt text.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.